CAROLYN HENDRICKS, M.D.
Specialist · BETHESDA, MD
Individual Active NPI 1205896776
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 716 | 116,443 | $8,359,956 | $2,330,822 | $1,850,069 |
| 2023 | 695 | 169,208 | $11,106,235 | $3,091,553 | $2,457,964 |
| 2022 | 738 | 166,836 | $9,825,575 | $2,591,603 | $2,057,693 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | 9,750 | $1 | $1 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 8,600 | $3 | $2 |
| J9271 | Injection, pembrolizumab, 1 mg | 6,800 | $55 | $44 |
| J9267 | Injection, paclitaxel, 1 mg | 6,642 | $0 | $0 |
| J0185 | Injection, aprepitant, 1 mg | 5,850 | $2 | $1 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 4,500 | $49 | $39 |
| J0897 | Injection, denosumab, 1 mg | 3,240 | $25 | $20 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,480 | $47 | $37 |
| J9395 | Injection, fulvestrant, 25 mg | 1,900 | $8 | $6 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 1,400 | $20 | $16 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,387 | $0 | $0 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 950 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Specialist | 174400000X | ✓ | — | — |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Specialist providers in Maryland
- NPI 1811133911
- NPI 1285722595
- NPI 1184616377
- NPI 1679753958
- NPI 1265439392
- NPI 1063450492
- NPI 1245501451
- NPI 1174919278
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.